Mucormycosis Infection in Dialysis Patients
Authors: JOHAN R. BOELAERT
Journal: Annals of Internal Medicine (1987)

Letters and Corrections1 November 1987Mucormycosis Infection in Dialysis PatientsJOHAN R. BOELAERT, M.D., PHILIPPE L. VERGAUWE, M.D., JOZEF M. VANDEPITTE, M.D.JOHAN R. BOELAERT, M.D.Search for more papers by this author, PHILIPPE L. VERGAUWE, M.D.Search for more papers by this author, JOZEF M. VANDEPITTE, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-107-5-782_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Veis and associates (1) reported fatal rhinocerebral mucormycosis in two nondiabetic dialysis patients receiving deferoxamine. Fatal mucormycosis developed in two of our patients on dialysis for 10 and 14 years, respectively, and receiving deferoxamine for 4 to 7 months, respectively. Several analogous cases have been reported (2). Because most of these patients were receiving deferoxamine, which is a siderophore, deferoxamine may serve as a growth factor for this fungus.Deferoxamine has also been incriminated in the pathogenesis of infections withYersinia enterocolitica. We reported 11 cases of bacteremia withYersinia(Y. enterocoliticain 10 cases andY....References1. VEISCONTIGUGLIAKLEINMISHELLALFREYSHAPIRO JRMJAJ. Mucormycosis in deferoxamine-treated patients on dialysis [Letter]. Ann Intern Med. 1987;107:258. LinkGoogle Scholar2. GOODILLABUELO JJ. Mucormycosis: a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload? [Letter]. N Engl J Med. 1987;317:54. CrossrefMedlineGoogle Scholar3. BOELAERTVAN LANDUYTVALCKE JHY. The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients. J Infect Dis. 1987;156:384-7. CrossrefMedlineGoogle Scholar4. CHIESAPACIFICORENZULLI CLF. Yersinia abscesses and iron overload. JAMA. 1987;257:3230-1. CrossrefMedlineGoogle Scholar5. ROBINS-BROWNEPRPIC RJ. Effect of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immunol. 1985;47:774-9. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Algemeen Ziekenhuis St. Jan, Brugge 8000; Heilig Hart Ziekenhuis, Roeselare 8800 Catholic University of Leuven Leuven 3000 Belgium PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByMucormycosesFob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from FerrioxamineInfección fúngica invasiva mixta por Rhizomucor pusillus y Aspergillus niger en un paciente inmunocompetenteHost-iron assimilation: pathogenesis and novel therapies of mucormycosisMetal Ions and Infectious Diseases. An Overview from the ClinicThe high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesisFUNGAL MENINGITISAluminum Toxicity Following IV Use of Oral Methadone SolutionBone metabolism and disease in chronic kidney diseaseCase 9-2002Defects in Host Defense MechanismsSurvival factors in rhino-orbital-cerebral mucormycosisDefects in Host Defense MechanismsFailure of Deferoxamine to Improve Iron Overload in Chronic Hemodialysis Patients11 The toxic effects of desferrioxamine 1 November 1987Volume 107, Issue 5Page: 782-783KeywordsBacteremiaGrowth factorsMedical dialysisPathogenesisRhinovirus infection Issue Published: 1 November 1987 PDF DownloadLoading ...